Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients

被引:8
|
作者
Zhang, Ziyin [1 ,2 ]
Zhang, Lu [1 ,2 ]
Jiang, Wangyan [1 ,2 ]
Du, Tingting [1 ,2 ]
Yuan, Gang [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan 430030, Peoples R China
[2] Branch Natl Clin Res Ctr Metab Dis, Wuhan, Peoples R China
关键词
Non-obese non-alcoholic fatty liver disease; Cardio-metabolic risk; Type 2 diabetes mellitus; FATTY LIVER-DISEASE; PREVALENCE; ASSOCIATION;
D O I
10.1186/s12933-022-01648-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Non-obese non-alcoholic fatty liver disease (NAFLD) has been reported to share clinical outcomes with its obese counterpart in the general population. However, conflicting results have been observed regarding the cardio-metabolic risk profile of non-obese NAFLD as compared to obese NAFLD. Moreover, in the context of type 2 diabetes mellitus (T2DM), this issue has been even less addressed. We hence aimed to examine the association of NAFLD with the cardio-metabolic risk profile in patients with T2DM according to their obesity status. Methods A total of 2,708 patients with T2DM who were hospitalized between June 2018 and May 2021 were cross-sectionally assessed. Results The prevalence of NAFLD was 49.3%. NAFLD was found in 34.1% of non-obese patients and 66.0% of obese patients. Non-obese NAFLD patients had more and worse metabolic disorders than obese patients without NAFLD in both men and women. Comparable cardio-metabolic risk profiles were noted between non-obese and obese NAFLD subjects. The associations of worse cardio-metabolic risk profiles with NAFLD were overall stronger in non-obese than in obese subjects among women with T2DM, while more pronounced in obese than in non-obese subjects among men with T2DM. Conclusion In patients with T2DM, non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD. The associations of metabolic disorders with NAFLD were stronger in non-obese than in obese patients in women patients with T2DM.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Metabolic surgery in non obese type 2 diabetic patients
    Berry, Marcos
    OBESITY SURGERY, 2010, 20 (08) : 981 - 981
  • [22] Association between TyG-related parameters and NAFLD risk in Japanese non-obese population
    Wang, Xiuli
    Liu, Jie
    Yu, Ke
    Huang, Zhenhua
    Liu, Hanxiong
    Li, Xiang
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [23] Subtracted Adulthood Mass Index - a new index to predict NAFLD risk in non-obese individuals
    Kiyak, Ata
    Elibol, Serra
    Barutcu, Ozlem
    Saruc, Murat
    Tozun, Nurdan
    HEPATOLOGY FORUM, 2021, 2 (01): : 26 - 30
  • [24] COMPARATIVE STUDY OF SERUM LIPID PROFILE IN OBESE TYPE 2 DIABETIC PATIENTS WITH OBESE NON DIABETIC PATIENTS
    Darshna, Jain
    Shaikh, M. K. S.
    Jha, R. K.
    Shilpa, Mittal
    Deepasha, Shahi
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (65): : 14129 - 14136
  • [25] Better Long-Term Glycemic Control in Non-Obese Type Than Obese Type in Young Korean Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    Lee, Eun Jung
    Song, Kee-Ho
    Kim, Suk Kyeong
    DIABETES, 2011, 60 : A695 - A695
  • [26] Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications
    Satoh, Ken
    Nagasawa, Kan
    Takebe, Noriko
    Kinno, Hirofumi
    Shozushima, Masaharu
    Onodera, Ken
    Oda, Tomoyasu
    Hasegawa, Yutaka
    Satoh, Jo
    Ishigaki, Yasushi
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 201 - 212
  • [27] Comparison in renal histology between Japanese obese and non-obese microalbuminuric type 2 diabetic patients
    Kanauchi, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (04) : 849 - 850
  • [28] Rosiglitazone is effective in obese and non-obese patients with Type 2 diabetes
    Deacon, L
    Donnelly, S
    Stewart, M
    Hand, L
    DIABETES, 2001, 50 : A433 - A433
  • [29] Relationship between uric acid and visceral fat in obese and non-obese type 2 diabetic patients
    Pankiv, VI
    Sydorchuk, IJ
    Kyryliuk, MD
    DIABETOLOGIA, 2001, 44 : A181 - A181
  • [30] Comparison of unique clinical indicators of non-alcoholic fatty liver disease (NAFLD) in obese and non-obese (lean) patients.
    Modi, AA
    Chuang, AZ
    Zela, SA
    Ankoma-Sey, V
    HEPATOLOGY, 2004, 40 (04) : 586A - 586A